Integrated Bioinformatics Analysis of Differentially Expressed RNA-Binding Proteins in Human Gliomas

Area of Science:

• Neuro-oncology
• Molecular Biology
• Genomics

Background:

• Gliomas are lethal central nervous system (CNS) cancers characterized by significant heterogeneity.
• Interactions involving RNA-binding proteins (RBPs) are increasingly recognized as critical in glioma pathogenesis.

Purpose of the Study:

• To identify and characterize differentially expressed RBPs in gliomas.
• To explore the functional roles and regulatory networks of these RBPs in glioma progression.
• To discover potential therapeutic targets among dysregulated RBPs.

Main Methods:

• Utilized RNA sequencing data from The Cancer Genome Atlas (TCGA) to identify differentially expressed genes (DEGs).
• Selected differentially expressed RBPs and analyzed their transcriptomic changes, interactome, and pathways using in silico methods.
• Constructed and topologically analyzed regulatory networks of identified RBPs.

Main Results:

• Identified key RBPs (e.g., PABPC1, EIF4A2, RPS3) involved in alternative splicing and ribosomal biogenesis.
• Found RBPs (e.g., YBX1, ELAVL2) potentially associated with stress granule formation in gliomas.
• Highlighted mutated RBPs (e.g., RPSA, RPL5) and RBPs (e.g., RPS8, EEF1A1) correlated with patient survival.

Conclusions:

• Several candidate RBPs show significant alterations and correlations with glioma progression and patient outcomes.
• These identified RBPs, particularly those in splicing and ribosome biogenesis, are promising targets for novel glioma therapies.
• Further investigation into these RBPs could lead to advancements in oncological strategies against gliomas.